71 related articles for article (PubMed ID: 25338559)
21. [Characteristics of NOTCH1 mutation in adult T-cell acute lymphoblastic leukemia].
Lin ZK; Zhang R; Ge Z; Liu J; Guo X; Qiao C; Wu YJ; Qiu HR; Zhang JF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1403-8. PubMed ID: 24370020
[TBL] [Abstract][Full Text] [Related]
22. LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
Menter T; Dirnhofer S; Tzankov A
J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
[TBL] [Abstract][Full Text] [Related]
23. Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma.
Walther N; Ulrich A; Vockerodt M; von Bonin F; Klapper W; Meyer K; Eberth S; Pukrop T; Spang R; Trümper L; Kube D
Am J Pathol; 2013 Apr; 182(4):1092-8. PubMed ID: 23375451
[TBL] [Abstract][Full Text] [Related]
24. Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of
Wang CJ; Jia MZ; Deng LP; Li WJ; Zhang Q; Zhang TJ; Li SY; Cui L; Li ZG
Pediatr Hematol Oncol; 2022 Sep; 39(6):549-560. PubMed ID: 35139734
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
[TBL] [Abstract][Full Text] [Related]
26. High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia.
Erdfelder F; Hertweck M; Filipovich A; Uhrmacher S; Kreuzer KA
Hematol Rep; 2010 Jan; 2(1):e3. PubMed ID: 22184516
[TBL] [Abstract][Full Text] [Related]
27. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
28. Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
Pellagatti A; Marafioti T; Paterson JC; Malcovati L; Della Porta MG; Jädersten M; Pushkaran B; George TI; Arber DA; Killick S; Giagounidis A; Hellström-Lindberg E; Cazzola M; Wainscoat JS; Boultwood J
Br J Haematol; 2009 Jun; 146(1):86-90. PubMed ID: 19438482
[TBL] [Abstract][Full Text] [Related]
29. [Characteristics and Clinical Significance of CRLF2 Mutations in Adult Acute Lymphoblastic Leukemia].
Gu Y; Wu YJ; Han Q; Zhou XL; Qiao C; Li JY; Ge Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):328-333. PubMed ID: 28446270
[TBL] [Abstract][Full Text] [Related]
30. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
[TBL] [Abstract][Full Text] [Related]
31. Drug resistance and BCR-ABL kinase domain mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement.
Soverini S; De Benedittis C; Papayannidis C; Paolini S; Venturi C; Iacobucci I; Luppi M; Bresciani P; Salvucci M; Russo D; Sica S; Orlandi E; Intermesoli T; Gozzini A; Bonifacio M; Rigolin GM; Pane F; Baccarani M; Cavo M; Martinelli G
Cancer; 2014 Apr; 120(7):1002-9. PubMed ID: 24382642
[TBL] [Abstract][Full Text] [Related]
32. NRAS mutations in de novo acute leukemia: prevalence and clinical significance.
Dunna NR; Vuree S; Anuradha C; Sailaja K; Surekha D; Digumarti RR; Rao VR; Yadav SK; Reddy R; Vishnupriya S
Indian J Biochem Biophys; 2014 Jun; 51(3):207-10. PubMed ID: 25204082
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia.
Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
[TBL] [Abstract][Full Text] [Related]
34. Differential binding of Lef1 and Msx1/2 transcription factors to Dkk1 CNEs correlates with reporter gene expression in vivo.
Lieven O; Dronka J; Burmühl S; Rüther U
PLoS One; 2014; 9(12):e115442. PubMed ID: 25545010
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB regulates Lef1 gene expression in chondrocytes.
Yun K; Choi YD; Nam JH; Park Z; Im SH
Biochem Biophys Res Commun; 2007 Jun; 357(3):589-95. PubMed ID: 17445771
[TBL] [Abstract][Full Text] [Related]
36. [Abnormal expression of hMSH2 mRNA and mutation P53 protein in acute lymphoblastic leukemia].
Lin XY; Sun L; Zou HZ; Le XP; Guo XJ; Liu YF; Sun H; Zou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):948-50. PubMed ID: 16403256
[TBL] [Abstract][Full Text] [Related]
37. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
[TBL] [Abstract][Full Text] [Related]
38. Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma.
Su MC; Chen CT; Huang FI; Chen YL; Jeng YM; Lin CY
J Formos Med Assoc; 2014 Dec; 113(12):934-9. PubMed ID: 24021930
[TBL] [Abstract][Full Text] [Related]
39. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
40. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
